Cargando…

Pharmacogenetics of ugt genes in North African populations

Detalles Bibliográficos
Autores principales:	Gaibar, M., Novillo, A., Romero-Lorca, A., Esteban, M. E., Fernández-Santander, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150910/ https://www.ncbi.nlm.nih.gov/pubmed/30061569 http://dx.doi.org/10.1038/s41397-018-0034-4

Ejemplares similares

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer
por: Gaibar, Maria, et al.
Publicado: (2020)

Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types
por: Romero-Lorca, Alicia, et al.
Publicado: (2018)

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
por: Gaibar, María, et al.
Publicado: (2022)

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
por: Novillo, Apolonia, et al.
Publicado: (2023)

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer
por: Gaibar, María, et al.
Publicado: (2021)

Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients
por: Fernández-Santander, Ana, et al.
Publicado: (2013)

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer
por: Novillo, Apolonia, et al.
Publicado: (2021)

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
por: Novillo, Apolonia, et al.
Publicado: (2020)

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Romero-Lorca, Alicia, et al.
Publicado: (2021)

The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety
por: Ching, Nathan R, et al.
Publicado: (2018)

Role of the UGT2B17 deletion in exemestane pharmacogenetics
por: Luo, Shaman, et al.
Publicado: (2017)

The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions
por: Marques, Sara Correia, et al.
Publicado: (2010)

UGT1A1 (TA)(n) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia
por: Vukovic, M, et al.
Publicado: (2018)

Pharmacogenetics of CYP2A6, CYP2B6, and UGT2B7 in the Context of HIV Treatments in African Populations
por: Ford, Graeme R., et al.
Publicado: (2022)

P450 Pharmacogenetics in Indigenous North American Populations
por: Henderson, Lindsay M., et al.
Publicado: (2018)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
por: de With, Mirjam, et al.
Publicado: (2023)

A review of clinical pharmacogenetics Studies in African populations
por: Radouani, Fouzia, et al.
Publicado: (2020)

Pharmacogenetics of uridine diphosphate glucuronosyltransferase (UGT2B7) genetic polymorphism on valproic acid pharmacokinetics in epilepsy
por: Munisamy, Murali, et al.
Publicado: (2014)

Analysis of pharmacogenetic traits in two distinct South African populations
por: Ikediobi, Ogechi, et al.
Publicado: (2011)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

New date for North West study day
Publicado: (2020)

New date for North West study day
Publicado: (2020)

UN highlights North Korea in appeal for aid
por: Watts, Jonathan
Publicado: (2003)

Distribution of selected gene polymorphisms of UGT1A1 in a Saudi population
por: Alkharfy, Khalid M., et al.
Publicado: (2013)

Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
por: Rego-Pérez, Ignacio, et al.
Publicado: (2008)

North Korea attacks Covid-19 research bodies
Publicado: (2021)

Genetic Variations and Haplotype Diversity of the UGT1 Gene Cluster in the Chinese Population
por: Yang, Jing, et al.
Publicado: (2012)

Polymorphisms of UGT1A1(*)6, UGT1A1(*)27 & UGT1A1(*)28 in three major ethnic groups from Malaysia
por: Teh, L. K., et al.
Publicado: (2012)

Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?
por: Oelofse, Carola, et al.
Publicado: (2023)

Comprehensive Variant Screening of the UGT Gene Family
por: Kim, Jason Yongha, et al.
Publicado: (2014)

Pharmacogenetics: detecting sensitive populations.
por: Shields, P G
Publicado: (1994)

Genome-Wide Analysis of UGT Genes in Petunia and Identification of PhUGT51 Involved in the Regulation of Salt Resistance
por: Dong, Lili, et al.
Publicado: (2022)

UGT1A1 is a major locus influencing bilirubin levels in African Americans
por: Chen, Guanjie, et al.
Publicado: (2012)

Unraveling African diversity from a cross‐disciplinary perspective
por: Fortes‐Lima, Cesar, et al.
Publicado: (2019)

John Nkengasong: building African autonomy to support global health
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nofgsgca9luf4mq06glob47glr